NNVC

Nanoviricides Inc

$1.12

-0.09 (-7.44%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$6.50
(+480.36%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
NanoViricides Inc. (NNVC) is a pioneering nanobiopharmaceutical company based in Shelton, Connecticut, focused on the development of innovative antiviral therapies through its proprietary nanomedicine platform. The firm is dedicated to addressing a range of viral infections and significant unmet medical needs, advancing its clinical and preclinical pipeline that holds promise for substantial growth within the expansive antiviral market. With a commitment to transforming healthcare through targeted treatments, NanoViricides is actively working to commercialize its advanced therapeutic solutions, positioning itself as a key player in the fight against viral diseases.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
1 CONTROLS DRIVE, SHELTON, CT, UNITED STATES, 06484
Fiscal year end:
June
Market capitalization:
$24.2 Million
EBITDA:
-$7.54 Million
PERatio:
0.0
EPS:
-0.5
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.236

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-95%
How much will you get:
$48
Prices dates:
31-12-2015: $23.60 and 31-12-2025: $1.13